INTRODUCTION

The eye is the most important sensory organ of the human body. Up to 83 per cent of all impressions are perceived by means of sight and the lost of this sensory function results in significant restrictions.
Globally, cataract is the second most common reason for visual impairment, so it is not surprising that cataract surgery is the most frequently performed surgical procedure in many developed countries. Still, the surgical procedure  used to today is far from perfect and continues to present challenges and risks. Because vision is so important to quality of life, all medical personnel involved in this sight-restoring procedure are highly motivated to seek continuous improvement in surgical outcomes and patient safety. Ultrasound (US) phacoemulsification has continuously developed and refined since its introduction in 1967. Today it represents the method of choice for the effective removal of cataracts.
The evolution of ophthalmological lasers has resulted in the continuous implementation of newer systems, such as nanosecond laser, in cataract surgery. Since the first report of "phacolysis of a human cataractous lens“ by a neodymium:YAG (Nd:YAG) laser in 1991, this technology has evolved immensly over the last decades. Derived from experience with the Nd:YAG laser capsulotomy, the Dodick photolysis is based on the physical principles of plasma formation and shock-wave generation, that are used for fragmentation of the lens nucleus of cataract patients. Lower energy consumption during the photolysis process, the ability to eliminate corneal thermal damage related to phacoemulsification use and the reduction of potential corneal endothelial loss induced by intraocular energy release during phacoemulsification seem to be interesting advantages oft this technique.
The aim of this study was to compare intraoperative effectiveness and postoperative tissue trauma after using the nanosecond laser-technique with the results after conventional manual phacoemulsification cataract surgery.

PATIENTS AND METHODS

A prospective randomized double-masked interventional trial was performed between March 2014 and March 2015. Recruitment and all surgical procedures were performed at the Department of Ophthalmology at the Charlottenklinik in Stuttgart, Germany. This study conformed to the tenets of the Declaration of Helsinki and was approved by the Ethics Committee (Bezirksärztekammer Nordwürttemberg, Germany). Informed consent was obtained from all patients.
Sixty-two eyes of 35 cataract patients were enrolled and randomised in two groups.  Group 1 received bilateral catarct surgery using phacoemulsification and in group 2 the nanosecond laser-assisted cataract surgery was applied in both eyes.
Patients with bilateral visually significant cataracts and a minimum best corrected visual acuity of 20/100 were eligible for inclusion. Exclusion criteria included age younger than 50 years, patients with preexisting low endothelial cell counts (ECCs) (<1800/mm) or clinically detectable pathological alterations of the anterior segment (such as corneal opacities, keratoconus, chronic uveitis, zonular dialysis, pseudoexfoliation syndrome, glaucoma and diabetes), previous intraocular inflammation or trauma, other ocular pathologies impairing visual function and previous anterior or posterior segment surgery. All surgical procedures were performed by the same experienced surgeon.

Examinations

Preoperatively, all patients had a complete eye examination comprising uncorrected distance visual acuity, corrected distance visual acuity, intraocular pressure (IOP) measurement, slitlamp examination of the anterior and posterior segment with undilated and dilated pupils, respectively. In addition, data were collected on axial length (AL), anterior chamber depth (ACD) and biometry measured using partial coherence interferometry (IOLMaster 500 Carl Zeiss Meditec AG). Biometry was performed a maximum of 6 months before surgery.
Other evaluations included the endothelial cell count (ECC), measured by means of noncontact specular microscopy (EM-3000, Tomey Corp.) and central corneal thickness (CT), measured with a Scheimpflug imaging system (Pachycam, Oculus Optikgeräte GmbH). Endothelial cell density was calculated by counting the number of cells within an area of interest of 250 x 250 µm. Cell densities are reported as number of cells per square millimeter (cell/mm2).
To classify the cataracts the nuclear opacity (NO) as a measure of nucleus hardness was chosen from the Lens Opacities Classification System III (LOCS III).

Surgical Technique

The surgical protocol for both groups was based on the standard small-incision clear corneal technique. The study eye was dilated, and topical anesthesia was administered repeatedly before the start of the operation. All surgical procedures were performed using standard surgical equipment. The basic steps for both techniques included capsulorrhexis, hydrodissection, hydrodelineation, cataract removal, cortical cleanup and IOL implantation.
Three clear corneal incisions tunnel were created (2.40 mm main incision and 2 side ports) with the main incision being on the steepest corneal meridian.. The capsulorhexis was created using the continuous curvilinear capsulorhexis (CCC) technique before hydrodissection and hydrodelineation was done. In all cases, residual cortex was removed using bimanual irrigation/aspiration. A Venturi-based vacuum systems with maximal intraoperative aspiration set between 250 and 300 mmHg was used. After bimanual cortical cleanup the capsular bag was inflated with sodium hyaluronate 1.0% (Provisc) and a hydrophobic acrylic IOL (XXXX, Alcon Surgical, Inc.) was placed in the capsular bag using an IOL injector. The viscoelastic substance was carefully removed from the anterior chamber and the capsular bag. After the anterior chamber was filled with balanced salt solution, the paracenteses were secured by stromal hydration, no suture was used.
Postoperatively, patients were prescribed topical Moxifloxacin hydrochloride 5,45 mg 6 times daily for 1 week as well as dexamethasone 1.0 mg 6 times daily for 4 weeks.

Cataract removal

In the control group phacoemulsification was performed using a divide-and-conquer approach or phaco-chop technique (Pentasys 2, Ruck Company,  Aachen, Germany) depending on the lens hardness.
In the nanolaser group an updated laser system (Cetus, ARC Laser GmbH) was used for the cataract extraction. This system is composed by a base that contains a 1064 nm wavelength Q-switched Nd: YAG laser and an optic fiber that transmits the laser impulse to a handpiece. The generated laser pulses are routed via a flexible 340 µm quartz fiber through the laser handpiece with a pulse energy of 5,5 mJ/pulse and a pulse duration of 4 to 5 nanoseconds in a frequency up to 10 Hz. The pulsing photic energy is focused on a 45 degree bent titanium platelet within the probe tip and induces an optical breakdown and plasma formation. This creates a shockwave that emanates from the tip in a cone-like fashion12  and leads to a fragmentation of the cataract substance. The disrupted particles of the cataract are continuously aspirated out of the eye through a aspiration port within the laser by a Geuder Megatron irrigation/ aspiration unit.. Irrigation is performed with a separate handpiece.
For effective fragmentation with this technique intimate contact of the laser-aspiration probe with the lens material is necessary. The probe position throughout the photolysis sequence is with the opening facing posteriorly away from the corneal endothelium. This offers maximal fragmentation and minimal endothelial surface exposure to released energy.
The energy required intraoperatively for removal of the cataract is calculated by the number of laser pulses that are needed for the fragmentation of the lens nucleus and varies significantly according to lens density and surgeon experience.
The Cetus nanosecond laser system already received the CE (Conformité Européenne) mark for clinical use within the European Union and 510K approval from the U.S. Food and Drug Administration for clinical use in the United States.

Main outcome measures

On the day of surgery the primary evaluted effectiveness endpoint was the the effective phaco-/photofragmentation time (EPT), which is the time to emulsify and extract the cataractous lens via the phacoemulsification or phacolysis probe, respectively. Other effectiveness endpoints included the mean phaco-/photofragmentation energy and volume of balanced salt solution used within the eye during the surgery process. After the completion of the cataract removal and intraocular lens (IOL) implantation, all patients were evaluated for the following postoperative parameters (main outcome measures) at 1 day, 7 days, 30 days and 90 days´ follow-up: uncorrected and distance corrected visual acuity (UDVA and CDVA, respectively), corneal endothelial cell count and central corneal thickness. However, the measurement of the central corneal thickness was performed only three times after cataract surgery (1 day, 30 days and 90 days postoperative).

Statistical Analysis

Sample size estimates for this study were based on the primary outcome measure of visual acuity at 6-month follow-up. For α=0.05 and 1−β=0.85, a sample size of 19 patients per group is sufficient to detect mean differences of one standard deviation or greater with a student’s t-test. A second sample size was calculated for endothelial cell loss based on the results reported by Tanev et al. (2016) at six months a level of α=0.05 and β=0.95, yielding a sample size of 30 patients per group. Anticipating a 5% loss to follow-up over the original six-month duration of the study for the larger required sample size, we enrolled 32 patients per group.
Statistical analyses were performed using SPSS software (version 21, International Business Machines Corp.). For comparison of clinical characteristics between groups, categorical data were analyzed using the Wilcoxon-Mann-Whitney U test and continuous data using two-sample t tests. Differences were accepted as significant when the P value was less than 0.05.

RESULTS

The study comprised 61 eyes of 35 patients. Phacoemulsification was performed in 29 eyes and 32 eyes had the nanosecond laser procedure. All surgeries were uneventful. There were no differences in demographic data and clinical characteristics between both groups.

Visual outcome

Postoperatively UDVA and CDVA increased significantly in both groups during the follow-up period. There were not significantly different between the two groups at different time points. In Group 1, the uncorrected visual acuity (UDVA) improved from 0,2 (median) at baseline to 0.6 on the first postoperative day and 0,7 after 3 months. In Group 2, UDVA improved from 0.25 (median) to 0.50 immediately after surgery and 0.5 at the end of follow- up. Corrected distance visual acuity (CDVA) improved from 0,5 (median) at baseline to 0.7 on the first postoperative day and 1,0 after 3 months. In Group 2, CDVA improved from 0.5 (median) to 0.7 immediately after surgery and 0.9 at the end of follow- up.

Intraoperative surgical parameters

The mean EPT was statistically significantly less in the phacoemulsification group (59,7 seconds ± 57,0 [SD]) than in the nanolaser group (138,7 ± 68,8 seconds) (p < 0,0001). The operating time was less than 14 minutes in all cases, and there were no complications in either group.
The required energy differed significantly among the 2 groups (p < 0.0001).
The mean energy consumption while the phacoemuslification process in group 1 was  41,8 Joule ± 30,9 (SD). During phacolysis the Cetus device utilized on average 213 pulses of 5,5 mJ per pulse and used a total energy of  1,2 Joule ± 0,7(SD).
At least there also was a significant between-group difference in the balanced salt solution volume between both groups: 33,1 Milliliter ± 37,2 (SD) in the phacoemulsification group and 54,9 Milliliter ± 30,6 (SD) in the nanolaser group.

Outcomes in Endothelial cell count and central corneal thickness

Preoperatively the two groups did not present statistically significant differences for corneal endothelial cell count and corneal thickness at the center of the cornea. Postoperatively, there were no significant between-group differences (p > 0.05) in the endothelial cell count. The mean endothelial cell density was 2360 cells/mm ± 54 (SD) preoperatively and 2182 ± 76 cells/mm at 3 months in the US group and 2486 ± 45 cells/mm and 2386 ± 45 cells/mm, respectively, in the laser group. The largest decrement of endothelial cell count was observed in group 1 compared with preoperative values after 7 days and after 30 days in group 2.
The central corneal thickness showed also no statistically significant difference (p > 0.05) between group 1 and 2.  Both groups reached a maximum thickness at the 1st day and then returned to presurgery levels after 90 days.

DISCUSSION

In the present prospective, randomized, double masked, clinical interventional study, we evaluated the postoperative corneal tissue trauma and effectiveness of cataract removal using the nanosecond laser technique and compared it to cataract surgery using the established ultrasound (US) phacoemulsification.
Over the last 50 years phacoemulsification evolved in technique and instrumentation and has become the standard of care for patients undergoing cataract extraction in many parts of the industrialized world.
The Dodick photolysis system has also experienced significant evolution in the past 30 years and offers a technically new procedure of cataract extraction that appears to be an equivalent safe and effective alternative to phacoemulsification.
Laser energy has attracted interest as a means for cataractous lens fragmentation because it involves no risk of focal tissue heating, even under low or no flow of irrigting solution. Ultrasound on the other hand, emulsifies the crystalline lens through the direct action of the vibrating phaco needle, the jackhammer effect, and the indirect cavitation effects of microbubbles that produce heat and pressure and are believed to be an important factor in phacoemulsification-induced endothelial cell damage.
Another advantage and contributing factor to the safety of the nanolaser technology is the reduction of intraocular energy necessary for cataract removal. Direct and indirect effects of high energy levels during the fragmentation impair endothelial pump function and lead to corneal swelling. If endothelial cell damage is sufficiently severe, corneal decompensation can occur. In this trial, the mean energy used for cataract extraction performed by Nanolaser was 1,2 J. The energy required for lens removal with phacoemulsification is 36 times more than that with photolysis.
The most significant factor for endothelial cell damage an postoperative corneal edema is phacoemulsification/photofragmentation time. Kannellopoulos et al. reported that the nanolaser system was safe and effective for the removal of cataracts up to grade 3. Softer” nuclei of NO 1 were removed by the Dodick Photolysis technology in a timeframe comparable to that of phacoemulsification. Regarding more dense nuclei, the operative time with this new technology was longer, so that further improvements in technical- related and surgical-related parameters are required
In conclusion, the nanosecond laser–assisted cataract surgery has several potential significant advantages, including a reduced energy and heat release within the eye in comparison to phacoemulsificatio. Meanwhile the photofragmentation time is significantly longer and the consumption of irrigating solution higher than during phacoemulsification. Moreover both methods leed to a similar extent of endothelial cell loss and central corneal thickness increase as conventional phacoemulsification over a 3-month follow-up.
Considering the 50 years developing period of the phacoemulsification technique, the Dodick photolysis already achieves the same or partly even better results, despite a much shorter term of progression.tModifications and a refinement of this methode of cristalline lens extraction may lead to further improvements in the cataract surgery and benefits in patient comfort.